Dendreon Pharmaceuticals

WHO WE ARE:At Dendreonweretransforming the battle against cancer with personalized immunotherapy. Our flagship productPROVENGE (sipuleucel-T) was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancerutilizinga patients own immune cells to fight the dis

WHO WE ARE:At Dendreonweretransforming the battle against cancer with personalized immunotherapy. Our flagship productPROVENGE (sipuleucel-T) was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancerutilizinga patients own immune cells to fight the dis

WHO WE ARE:At Dendreonweretransforming the battle against cancer with personalized immunotherapy. Our flagship productPROVENGE (sipuleucel-T) was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancerutilizinga patients own immune cells to fight the dis

WHO WE ARE:At Dendreonweretransforming the battle against cancer with personalized immunotherapy. Our flagship productPROVENGE (sipuleucel-T) was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancerutilizinga patients own immune cells to fight the dis